Reported Earlier, Harmony Biosciences Shareholders Sell 8M Shares at $31 Each in Public Offering

Harmony Biosciences Holdings -2.48% Post

Harmony Biosciences Holdings

HRMY

33.00

33.00

-2.48%

0.00% Post

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) (the "Company") today announced the pricing of the previously announced underwritten public offering of an aggregate of 8,000,000 shares of the Company's common stock, par value $0.00001 per share ("Common Stock"), by Marshman Fund Trust II and Valor IV Pharma Holdings, LLC (together, the "Selling Shareholders") at a public offering price of $31.00 per share. The Selling Shareholders have granted the underwriter a 30-day option to purchase an additional 1,200,000 shares of Common Stock from the Selling Shareholders at the public offering price, less underwriting discounts and commissions. The Company is not offering any shares of Common Stock in the offering and will not receive any proceeds from the sale of shares in the offering. The offering is expected to close on November 1, 2024, subject to customary closing conditions.

Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via